BE877889A - Nouveaux derives de la pyrimidone, procedes pour leur preparation et leur utilisation comme medicaments - Google Patents

Nouveaux derives de la pyrimidone, procedes pour leur preparation et leur utilisation comme medicaments

Info

Publication number
BE877889A
BE877889A BE0/196449A BE196449A BE877889A BE 877889 A BE877889 A BE 877889A BE 0/196449 A BE0/196449 A BE 0/196449A BE 196449 A BE196449 A BE 196449A BE 877889 A BE877889 A BE 877889A
Authority
BE
Belgium
Prior art keywords
pyrimidone
preparation
methods
medicinal products
new derivatives
Prior art date
Application number
BE0/196449A
Other languages
English (en)
French (fr)
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BE877889A publication Critical patent/BE877889A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BE0/196449A 1978-07-26 1979-07-25 Nouveaux derives de la pyrimidone, procedes pour leur preparation et leur utilisation comme medicaments BE877889A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7831153 1978-07-26

Publications (1)

Publication Number Publication Date
BE877889A true BE877889A (fr) 1979-11-16

Family

ID=10498669

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/196449A BE877889A (fr) 1978-07-26 1979-07-25 Nouveaux derives de la pyrimidone, procedes pour leur preparation et leur utilisation comme medicaments

Country Status (14)

Country Link
US (1) US4524071A (de)
JP (1) JPS5540670A (de)
AU (1) AU534744B2 (de)
BE (1) BE877889A (de)
CH (1) CH642952A5 (de)
DE (1) DE2928842A1 (de)
DK (1) DK310779A (de)
ES (1) ES482869A1 (de)
FR (1) FR2433527A1 (de)
GB (1) GB2030979B (de)
IT (1) IT1117778B (de)
NL (1) NL7905775A (de)
SE (1) SE7906372L (de)
ZA (1) ZA793443B (de)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4649141A (en) * 1978-02-13 1987-03-10 Smith Kline & French Laboratories Limited Pyrimidine compounds
EP0058055B1 (de) * 1981-02-06 1987-09-23 Smithkline Beckman Corporation Verfahren zur Herstellung von substituierten Pyrimidinonen und deren Zwischenprodukte

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
US4607107A (en) * 1980-10-01 1986-08-19 Smith Kline & French Laboratories Ltd. (4-aminoalkyl-2-pyridyl alkyl)guanidines
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4620001A (en) * 1981-02-06 1986-10-28 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones
JPS58110681A (ja) * 1981-12-23 1983-07-01 Showa Denko Kk 純鉄の錆取り方法
IT1153066B (it) * 1982-11-18 1987-01-14 Mentedison S P A Derivati del pirimidin-4-one ad attivita' erbicida
PT77623B (en) * 1982-11-25 1986-03-19 Smith Kline French Lab Process for the preparation of a small class of histamine h2-antagonists
GB8311443D0 (en) * 1983-04-27 1983-06-02 Smith Kline French Lab Chemical compounds
GB8318638D0 (en) * 1983-07-09 1983-08-10 Smith Kline French Lab Chemical compounds
GB8320505D0 (en) * 1983-07-29 1983-09-01 Smith Kline French Lab Chemical compounds
GB8332091D0 (en) * 1983-12-01 1984-01-11 Smith Kline French Lab Chemical compounds
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
JO1410B1 (en) * 1984-11-03 1986-11-30 سميث كلاين اند فرينش لابوراتوريز ليمتد Vehicles
JPS61155373A (ja) * 1984-12-28 1986-07-15 Yamanouchi Pharmaceut Co Ltd 新規な２−置換アミノ−４（１ｈ）−ピリミドン誘導体及びその製造法
JPH02101170A (ja) * 1988-10-07 1990-04-12 Mitsubishi Electric Corp アルミニウム合金表面の前処理方法
JPH04323392A (ja) * 1991-04-19 1992-11-12 Nkk Corp チタン材の酸洗処理方法
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
IN146736B (de) * 1975-10-02 1979-08-25 Smith Kline French Lab
US4154834A (en) * 1975-12-29 1979-05-15 Smith Kline & French Laboratories Limited Substituted isocytosines having histamine H2 -antagonist activity
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IN151188B (de) * 1978-02-13 1983-03-05 Smith Kline French Lab

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649141A (en) * 1978-02-13 1987-03-10 Smith Kline & French Laboratories Limited Pyrimidine compounds
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
EP0058055B1 (de) * 1981-02-06 1987-09-23 Smithkline Beckman Corporation Verfahren zur Herstellung von substituierten Pyrimidinonen und deren Zwischenprodukte

Also Published As

Publication number Publication date
SE7906372L (sv) 1980-01-28
DE2928842A1 (de) 1980-02-14
ES482869A1 (es) 1980-09-01
AU534744B2 (en) 1984-02-16
IT1117778B (it) 1986-02-24
NL7905775A (nl) 1980-01-29
DK310779A (da) 1980-02-29
ZA793443B (en) 1980-12-31
GB2030979A (en) 1980-04-16
FR2433527B1 (de) 1982-10-15
FR2433527A1 (fr) 1980-03-14
AU4924979A (en) 1980-01-31
GB2030979B (en) 1983-03-02
CH642952A5 (de) 1984-05-15
IT7949849A0 (it) 1979-07-24
US4524071A (en) 1985-06-18
JPS5540670A (en) 1980-03-22

Similar Documents

Publication Publication Date Title
BE877889A (fr) Nouveaux derives de la pyrimidone, procedes pour leur preparation et leur utilisation comme medicaments
BE858283A (fr) Nouveaux derives de perhydro-aza-heterocycles utiles comme medicaments et procede pour leur preparation
BE869133A (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
BE873658A (fr) Nouveaux derives de la guanidine, leur preparation et leur application comme medicaments
FR2333504A1 (fr) Nouveaux derives de l'indazole, leur preparation et leur application comme medicaments
BE874683A (fr) Nouveaux derives bicyclo-octaniques leur preparation et leur utilisation comme medicaments
BE850668A (fr) Nouveaux esters-17 alpha hydroxy-17 alpha de progestatifs utiles comme medicaments et procedes de leur preparation
BE839967R (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
BE860613A (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments
FR2339598A1 (fr) Nouveaux derives de la pyrrolidine, leur preparation et leur application comme medicaments
LU81027A1 (fr) Nouveaux derives de la n-phenylalanine,leur preparation et leur application comme medicaments
BE883576A (fr) Nouveaux derives d'hydroxyamino-eburnane leur procede de preparation, intermediaires utiles et utilisation comme medicament et comme intermediaire
FR2341577A1 (fr) Nouveaux derives de la piperazine, leur preparation et leur application comme medicaments
BE869833A (fr) 2,3-polymethylene-4-oxo-4h-pyrido(1,2-a) pyrimidines utiles comme medicaments et procede pour leur preparation
FR2320090A1 (fr) Nouveaux derives de l'indole, leur preparation et leur application comme medicaments
BE863215A (fr) Nouveaux derives de la benzo (f) isoquinoleine, leur preparation et leur application comme medicaments
BE867339A (fr) Nouveaux derives de la 5-phenyl-1h-3-benzazepine, leur preparation et leur utilisation comme medicaments
BE866588A (fr) Derives de 2-benzyl-perhydroazepines, procede pour leur preparation et application comme medicaments
BE861337A (fr) Nouveaux derives imidazoliques leur procede de preparation et leur application comme medicaments
BE862303A (fr) Nouvelles 0-propyloximes substituees basiquement, leur procede de preparation et leur emploi comme medicaments
BE859084A (fr) Nouveaux derives de l'imidazo (5,1-a)isoquinoleine, leur preparation et leur application comme medicaments
FR2305183A1 (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
BE861137A (fr) Ortho-aminoacetophenones utiles comme medicaments et procede pour leur preparation
FR2335225A1 (fr) Nouveaux derives de l'isoquinoleine, leur preparation et leur application comme medicaments
FR2320103A1 (fr) Nouveaux derives de la morphanthridine, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: GLAXO GROUP LTD

Effective date: 19890731